Literature DB >> 21310929

Sobering realities of surviving Hodgkin lymphoma.

Kieron Dunleavy1, Catherine M Bollard.   

Abstract

Entities:  

Year:  2011        PMID: 21310929     DOI: 10.1182/blood-2010-11-317131

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Pediatric Hodgkin lymphoma: are we over-scanning our patients?

Authors:  N Rathore; H M Eissa; J F Margolin; H Liu; M F Wu; T Horton; K Kamdar; Z Dreyer; P Steuber; K R Rabin; M Redell; C E Allen; K L McClain; R P Guillerman; C M Bollard
Journal:  Pediatr Hematol Oncol       Date:  2012-05-25       Impact factor: 1.969

2.  Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.

Authors:  Conrad R Cruz; Ulrike Gerdemann; Ann M Leen; Jessica A Shafer; Stephanie Ku; Benjamin Tzou; Terzah M Horton; Andrea Sheehan; Amanda Copeland; Anas Younes; Cliona M Rooney; Helen E Heslop; Catherine M Bollard
Journal:  Clin Cancer Res       Date:  2011-09-09       Impact factor: 12.531

Review 3.  Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

Authors:  Kieron Dunleavy; Wyndham H Wilson
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

4.  Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.

Authors:  Kieron Dunleavy; Cliona Grant; Wyndham H Wilson
Journal:  Ther Adv Hematol       Date:  2013-02

Review 5.  Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

Authors:  Kieron Dunleavy; Cliona Grant; Franziska C Eberle; Stefania Pittaluga; Elaine S Jaffe; Wyndham H Wilson
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

Review 6.  Appropriate management of molecular subtypes of diffuse large B-cell lymphoma.

Authors:  Kieron Dunleavy; Wyndham H Wilson
Journal:  Oncology (Williston Park)       Date:  2014-04       Impact factor: 2.990

7.  Pruritic cutaneous lesions mimicking dermatitis artefacta in the course of mediastinal gray-zone lymphoma.

Authors:  Karolina Englert; Agata D Kłosowicz; Barbara Grześkowiak; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2020-05-06       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.